Italia markets closed

ILMN Dec 2024 270.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,45000,0000 (0,00%)
Alla chiusura: 04:03PM EDT
Schermo intero
Chiusura precedente0,4500
Aperto0,4500
Denaro1,2000
Lettera7,9000
Prezzo d'esercizio270,00
Scadenza2024-12-20
Min-Max giorno0,4500 - 0,4500
Contratto - Min-MaxN/D
Volume1
Open Interest3
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera